{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2025-09-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "codes": [
        {
          "uuid": "81ddb83c-52b9-4b68-a452-46ff8a389045",
          "code": "S01HA03",
          "comments": "ATC|SENSORY ORGANS|OPHTHALMOLOGICALS|LOCAL ANESTHETICS|Local anesthetics|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atc_ddd_index/?code=S01HA03&showdescription=yes",
          "code_system": "WHO-ATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "063c04c0-f030-40fc-ab9e-5e665ad8ef92",
          "code": "C05AD02",
          "comments": "ATC|CARDIOVASCULAR SYSTEM|VASOPROTECTIVES|AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|Local anesthetics|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atc_ddd_index/?code=C05AD02&showdescription=yes",
          "code_system": "WHO-ATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "f3ff2233-6886-4358-9577-1caf7a7ad03d",
          "code": "N01BA03",
          "comments": "ATC|NERVOUS SYSTEM|ANESTHETICS|ANESTHETICS, LOCAL|Esters of aminobenzoic acid|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atc_ddd_index/?code=N01BA03&showdescription=yes",
          "code_system": "WHO-ATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "2e4cab96-6f2a-400b-8322-305a35e7a88c",
          "code": "D04AB06",
          "comments": "ATC|DERMATOLOGICALS|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|Anesthetics for topical use|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atc_ddd_index/?code=D04AB06&showdescription=yes",
          "code_system": "WHO-ATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "e78b059d-f7d6-447c-8104-6d7c73060c05",
          "code": "N0000166743",
          "comments": "Chemical Ingredients [Chemical/Ingredient]|Organic Chemicals [Chemical/Ingredient]|Carboxylic Acids [Chemical/Ingredient]|Esters [Chemical/Ingredient]",
          "type": "PRIMARY",
          "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000166743",
          "code_system": "NDF-RT",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "b33721be-8c4f-4c30-a47c-9e33767e643c",
          "code": "N0000175683",
          "comments": "Established Pharmacologic Class [EPC]|Ester Local Anesthetic [EPC]",
          "type": "PRIMARY",
          "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175683",
          "code_system": "NDF-RT",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "646502f5-5245-40cf-a355-1ca7bb9e0bac",
          "code": "N0000175976",
          "comments": "Physiological Effects [PE]|Organ System Specific Effects [PE]|Nervous System Activity Alteration [PE]|Peripheral Nervous System Activity Alteration [PE]|Sensory System Activity Alteration [PE]|Local Anesthesia [PE]",
          "type": "PRIMARY",
          "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175976",
          "code_system": "NDF-RT",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "d36b30a4-8cf6-4806-b440-2ed2e9148fcf",
          "code": "QS01HA03",
          "comments": "VATC|OPHTHALMOLOGICALS|LOCAL ANESTHETICS|Local anesthetics|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QS01HA03&showdescription=yes",
          "code_system": "WHO-VATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "31d3836a-2070-4f6a-9576-2d03e28b8156",
          "code": "QN01BA03",
          "comments": "VATC|ANESTHETICS|ANESTHETICS, LOCAL|Esters of aminobenzoic acid|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN01BA03&showdescription=yes",
          "code_system": "WHO-VATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "5bf4f9f2-987a-4dca-b339-de1d7bc855f0",
          "code": "QD04AB06",
          "comments": "VATC|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.|ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS,  ETC.|Anesthetics for topical use|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QD04AB06&showdescription=yes",
          "code_system": "WHO-VATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "bcb4a480-3aa6-48b5-b3d9-fa7abcd7d019",
          "code": "QC05AD02",
          "comments": "VATC|VASOPROTECTIVES|AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|Local anesthetics|tetracaine",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC05AD02&showdescription=yes",
          "code_system": "WHO-VATC",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "15fe6b0a-e10d-4985-ad1f-407745e6990a",
          "code": "94-24-6",
          "type": "PRIMARY",
          "url": "https://commonchemistry.cas.org/detail?cas_rn=94-24-6",
          "code_system": "CAS",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd",
            "a92ab2e4-4259-48a6-9a96-89b5596185a7"
          ]
        },
        {
          "uuid": "25e62488-bbba-4972-b871-b41a4271cbc8",
          "code": "C66590",
          "type": "PRIMARY",
          "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C66590",
          "code_system": "NCI_THESAURUS",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "ea535e28-4a41-4388-833c-ec09f671b984",
          "code": "D013748",
          "type": "PRIMARY",
          "url": "http://www.ncbi.nlm.nih.gov/mesh/68013748",
          "code_system": "MESH",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "f1c24a35-aee2-4b73-b792-09d3fd3df29e",
          "code": "21 CFR 346.10",
          "comments": "PART 346 -- ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 346.10 Local anesthetic active ingredients.",
          "type": "PRIMARY",
          "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=346.10",
          "code_system": "CFR",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "d1883c3a-b78a-4286-8485-ec3935bd7eec",
          "code": "TETRACAINE",
          "type": "PRIMARY",
          "url": "https://en.wikipedia.org/wiki/Tetracaine",
          "code_system": "WIKIPEDIA",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "5f3c62d8-bd30-474e-acc6-bbcfc4f1d936",
          "code": "21.3",
          "comments": "WHO ESSENTIAL MEDICINES LIST|Ophthalmological preparations|Local anaesthetics",
          "type": "PRIMARY",
          "url": "http://prais.paho.org/medicine/320/?section=141#type692",
          "code_system": "WHO-ESSENTIAL MEDICINES LIST",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "7baa51f0-8d09-4e1a-9e9c-8bbef6e064f9",
          "code": "SUB10940MIG",
          "type": "PRIMARY",
          "code_system": "EVMPD",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "91c2cc5c-6694-41c8-946a-9f2ba80849ce",
          "code": "431",
          "type": "PRIMARY",
          "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=431",
          "code_system": "INN",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "7bbf7ac7-7eb1-40d7-bf68-4007eef7f59b",
          "code": "10391",
          "comments": "RxNorm",
          "type": "PRIMARY",
          "url": "https://rxnav.nlm.nih.gov/REST/rxcui/10391/allProperties.xml?prop=all",
          "code_system": "RXCUI",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "7889d671-c7ef-4669-b544-d5199196650a",
          "code": "DB09085",
          "type": "PRIMARY",
          "url": "http://www.drugbank.ca/drugs/DB09085",
          "code_system": "DRUG BANK",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "e7ca042b-d7fe-4788-bc90-a483990df876",
          "code": "21 CFR 524.1484B",
          "comments": "SUBCHAPTER E--ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS|PART 524 OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS|SEC. 524.1484b Neomycin, isoflupredone, tetracaine, and myristyl-gamma-picolinium powder.",
          "type": "PRIMARY",
          "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=524.1484b",
          "code_system": "CFR",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "02f23278-958b-4e64-83b8-d3e8346e7508",
          "code": "21 CFR 524.1484C",
          "comments": "SUBCHAPTER E--ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS|PART 524 OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS|SEC. 524.1484c Neomycin, isoflupredone, and tetracaine ointment.",
          "type": "PRIMARY",
          "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=524.1484c",
          "code_system": "CFR",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "ed71cd97-3ca7-4cf4-8046-311499300877",
          "code": "21 CFR 524.1484D",
          "comments": "SUBCHAPTER E--ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS|PART 524 OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS|SEC. 524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment.",
          "type": "PRIMARY",
          "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=524.1484d",
          "code_system": "CFR",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "a26b5af7-0fc2-4a5a-815b-c088185a898e",
          "code": "21 CFR 524.1484F",
          "comments": "SUBCHAPTER E--ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS|PART 524 OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS|SEC. 524.1484f Neomycin, prednisolone, and tetracaine otic suspension.",
          "type": "PRIMARY",
          "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=524.1484f",
          "code_system": "CFR",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "5268baa5-1dca-4fd9-8afc-3ccbd9743010",
          "code": "CHEMBL698",
          "type": "PRIMARY",
          "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698",
          "code_system": "ChEMBL",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "ecad24d3-902d-49d8-ae11-95687ab3903f",
          "code": "202-316-6",
          "type": "PRIMARY",
          "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.002.106",
          "code_system": "ECHA (EC/EINECS)",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "b8947f08-c675-4ea1-90fa-e7ad2bf33faa",
          "code": "5411",
          "type": "PRIMARY",
          "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5411",
          "code_system": "PUBCHEM",
          "references": [
            "bc285564-2b3f-4839-ac9b-435671c412bd"
          ]
        },
        {
          "uuid": "67e9a714-d7c0-daae-5837-2b44e0c90cb1",
          "code": "DTXSID1043883",
          "type": "PRIMARY",
          "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID1043883",
          "code_system": "EPA CompTox",
          "references": [
            "22d6ff94-df1e-1b7b-5240-9d907e800834"
          ]
        },
        {
          "uuid": "f1ad420f-c658-28fa-3dd3-ceeb42644162",
          "code": "Tetracaine",
          "type": "PRIMARY",
          "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM714/",
          "code_system": "LACTMED",
          "references": [
            "9167ec3a-a281-1614-423a-610c73e0f973"
          ]
        },
        {
          "uuid": "71a3c9f2-0399-0d18-ffe9-a65e499d0f50",
          "code": "N01BA53",
          "comments": "ATC|NERVOUS SYSTEM|ANESTHETICS|ANESTHETICS, LOCAL|Esters of aminobenzoic acid|tetracaine, combinations",
          "type": "PRIMARY",
          "url": "http://www.whocc.no/atc_ddd_index/?code=N01BA53&showdescription=yes",
          "code_system": "WHO-ATC"
        },
        {
          "uuid": "f4928d24-17c0-6680-e097-fa255fb70a90",
          "code": "C245",
          "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Anesthetic Agent",
          "type": "CONCEPT",
          "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C245",
          "code_system": "NCI_THESAURUS",
          "references": [
            "9167ec3a-a281-1614-423a-610c73e0f973"
          ]
        },
        {
          "uuid": "47d71b52-da82-4221-aca2-4ac255808a86",
          "code": "0619F35CGV",
          "type": "PRIMARY",
          "code_system": "FDA UNII"
        },
        {
          "uuid": "16e7ac25-2704-604b-c1b6-898380f4c666",
          "code": "2610",
          "type": "PRIMARY",
          "url": "https://drugcentral.org/drugcard/2610",
          "code_system": "DRUG CENTRAL",
          "references": [
            "9167ec3a-a281-1614-423a-610c73e0f973"
          ]
        },
        {
          "uuid": "19f39907-4dfc-4aa5-dd44-65d1d5c8a130",
          "code": "9468",
          "type": "PRIMARY",
          "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:9468",
          "code_system": "CHEBI",
          "references": [
            "9167ec3a-a281-1614-423a-610c73e0f973"
          ]
        },
        {
          "uuid": "197094fb-d0ee-5709-fdcb-54cfea92b2e2",
          "code": "1649991",
          "type": "PRIMARY",
          "url": "https://store.usp.org/product/1649991",
          "code_system": "RS_ITEM_NUM",
          "references": [
            "9167ec3a-a281-1614-423a-610c73e0f973"
          ]
        },
        {
          "uuid": "33668b41-d4a3-fc2d-0dea-3f5de69172f2",
          "code": "0619F35CGV",
          "type": "PRIMARY",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=0619F35CGV",
          "code_system": "DAILYMED",
          "references": [
            "c48a0687-deae-9405-7752-66188d16a1cc"
          ]
        },
        {
          "uuid": "83c050f3-5052-002a-3a30-951cb6371da1",
          "code": "100000088809",
          "type": "PRIMARY",
          "code_system": "SMS_ID",
          "references": [
            "1c60ae1e-c21d-037f-bf4c-f41734bedc54"
          ]
        }
      ],
      "relationships": [
        {
          "uuid": "8cf389ab-7de4-49d0-b980-9f9fa8a8679a",
          "type": "ACTIVE MOIETY",
          "related_substance": {
            "uuid": "fa846d64-5f44-4f99-a2cf-07ad19763299",
            "refuuid": "b78fc0df-04de-4eaf-b1ea-c76e2f4c483c",
            "name": "TETRACAINE",
            "unii": "0619F35CGV",
            "linking_id": "0619F35CGV",
            "ref_pname": "TETRACAINE",
            "substance_class": "reference"
          }
        },
        {
          "uuid": "86b4e9b6-de82-4070-9a28-190c34391b14",
          "type": "SALT/SOLVATE->PARENT",
          "related_substance": {
            "uuid": "7d90ec25-b1a8-478b-a3c9-757ab6b91a97",
            "refuuid": "a62f1cd0-0d99-40e2-ab71-79b52f21299f",
            "name": "TETRACAINE HYDROCHLORIDE",
            "unii": "5NF5D4OPCI",
            "linking_id": "5NF5D4OPCI",
            "ref_pname": "TETRACAINE HYDROCHLORIDE",
            "substance_class": "reference"
          }
        },
        {
          "uuid": "6aca28ef-c109-473a-8877-152c9ae4de90",
          "amount": {
            "uuid": "5f825b3a-b80e-475f-b4e8-d3a1421b057d",
            "type": "RELATIONSHIP_AMOUNT",
            "units": "WEIGHT PERCENT",
            "high_limit": 101,
            "low_limit": 98
          },
          "qualification": "USP",
          "type": "BASIS OF STRENGTH->SUBSTANCE",
          "interaction_type": "ASSAY (TITRATION)",
          "references": [
            "dc1d09ff-cf9b-48c1-8a32-e9cd8566a57e"
          ],
          "related_substance": {
            "uuid": "2d6919c5-6dda-4cac-926f-4efb350e8694",
            "refuuid": "b78fc0df-04de-4eaf-b1ea-c76e2f4c483c",
            "name": "TETRACAINE",
            "unii": "0619F35CGV",
            "linking_id": "0619F35CGV",
            "ref_pname": "TETRACAINE",
            "substance_class": "reference"
          }
        },
        {
          "uuid": "48df8a00-d813-44d1-b335-a6033100b5ae",
          "amount": {
            "uuid": "940de848-5ded-499f-8e4e-53b92f2a84bb",
            "units": "PERCENT PEAK AREA",
            "high_limit": 0.4
          },
          "qualification": "USP",
          "type": "IMPURITY->PARENT",
          "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)",
          "references": [
            "00d8fc89-5d5b-482c-92a3-2b14a29bcb0e"
          ],
          "related_substance": {
            "uuid": "4e48d887-0013-455c-a91e-9b89dcfb612d",
            "refuuid": "acf23515-b427-44eb-8c7d-fa82f4bdbab5",
            "name": "Aminobenzoic acid",
            "unii": "TL2TJE8QTX",
            "linking_id": "TL2TJE8QTX",
            "ref_pname": "Aminobenzoic acid"
          }
        },
        {
          "uuid": "d89a173d-a6d7-4116-8c59-73f97d392fc1",
          "amount": {
            "uuid": "7810f731-cf31-471b-ae7a-4aeb6c60c1b5",
            "units": "PERCENT PEAK AREA",
            "high_limit": 0.4
          },
          "qualification": "USP",
          "type": "IMPURITY->PARENT",
          "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)",
          "references": [
            "a355b97d-f360-4181-bf07-b56011bbab22"
          ],
          "related_substance": {
            "uuid": "3b69cbcc-311e-4767-9f21-d3778c56d8b3",
            "refuuid": "974f4de9-13a1-49dc-897a-6469f5ce3590",
            "name": "4-(BUTYLAMINO)BENZOIC ACID",
            "unii": "KGL80FSD2F",
            "linking_id": "KGL80FSD2F",
            "ref_pname": "4-(BUTYLAMINO)BENZOIC ACID"
          }
        },
        {
          "uuid": "2c4d9482-91d7-4f6e-92b1-cb6afaf180b5",
          "amount": {
            "uuid": "b4bf4d8c-b517-422a-a0f2-858964944076",
            "units": "PERCENT PEAK AREA",
            "high_limit": 0.4
          },
          "qualification": "USP",
          "type": "IMPURITY->PARENT",
          "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)",
          "references": [
            "3c47a492-f7e4-461a-893d-2bd6c799c80f"
          ],
          "related_substance": {
            "uuid": "7c520d11-69cc-446f-befe-b3075e222dc1",
            "refuuid": "a976d8cf-a0de-4d8d-ae40-fe39aefc9086",
            "name": "METHYL 4-(BUTYLAMINO)BENZOATE",
            "unii": "X9B9Y98RNJ",
            "linking_id": "X9B9Y98RNJ",
            "ref_pname": "METHYL 4-(BUTYLAMINO)BENZOATE"
          }
        },
        {
          "uuid": "b42300fb-8e41-402d-bb25-d1b8a50b5084",
          "amount": {
            "uuid": "f63ba4a7-0952-47dd-bf0c-a28da3a593ed"
          },
          "type": "IMPURITY->PARENT",
          "references": [
            "26dadd46-3536-473f-85d2-62f8b0c16d96"
          ],
          "related_substance": {
            "uuid": "675c2623-7f32-479a-9fc8-4a880fdcf9fc",
            "refuuid": "c1e667ae-59c2-45e6-9584-e0f098103b88",
            "name": "N-nitroso-tetracaine",
            "unii": "L7EP2YEA9S",
            "linking_id": "L7EP2YEA9S",
            "ref_pname": "N-nitroso-tetracaine",
            "substance_class": "reference"
          }
        },
        {
          "uuid": "e9bc9279-91ab-406a-8abd-0cccc019f00e",
          "amount": {
            "uuid": "645a27dc-6a21-4b7b-a4fa-dcfe6eb5446f"
          },
          "type": "IMPURITY->PARENT",
          "references": [
            "bab46137-12be-4c22-b6f0-13a0b8f982f4"
          ],
          "related_substance": {
            "uuid": "523cb183-73bb-4bb0-a06a-a3d271048581",
            "refuuid": "c3ddcdd5-6210-4bb9-a9b1-3995b9fa1806",
            "name": "N-nitroso-desmethyl-tetracaine",
            "unii": "3R7WEZ8R7G",
            "linking_id": "3R7WEZ8R7G",
            "ref_pname": "N-nitroso-desmethyl-tetracaine",
            "substance_class": "reference"
          }
        }
      ],
      "substance_class": "chemical",
      "names": [
        {
          "uuid": "2495d034-0430-488b-abfa-43f6598de99d",
          "name": "AMETHOCAINE",
          "stdName": "AMETHOCAINE",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "d967f3e2-444e-4ef6-b975-6df3c48a7e43"
          ],
          "display_name": false
        },
        {
          "uuid": "304fa230-5041-4493-ae86-d7fc184bcdf7",
          "name": "SYNERA COMPONENT TETRACAINE",
          "stdName": "SYNERA COMPONENT TETRACAINE",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "f2a20f26-2136-47cf-9f4b-3a00a64ec991",
            "8b7bc73d-2b1a-4889-8697-b94174b0bdae"
          ],
          "display_name": false
        },
        {
          "uuid": "5f66c9b4-98d0-4579-bd84-595515e9fe29",
          "name": "TETRACAINE",
          "stdName": "TETRACAINE",
          "type": "of",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "1f60b997-985e-46bf-a5b1-b8aeaf8af9a0",
            "8004931f-572e-4a9d-86e9-32a78195eccf",
            "c9ad087f-6ffb-4460-81d4-2092220efffe",
            "1195c0f1-bd16-4f0d-83ad-6c0e6cd4aa3b",
            "00436c54-39f7-4dbc-8a67-5c4ef34a91e5",
            "dcc93b8f-d1e9-463b-961f-e7a07b61eb18",
            "c05e0135-400d-4cea-beb7-9e7a082d9c38",
            "fad0ef1a-9e39-457c-8ec5-1239b45ecdbb",
            "f2723895-2d93-46f9-b6fd-2567d4a2561a",
            "5107178e-00b8-4705-8b63-70365e6323b7",
            "13528cc5-a3c0-4040-8f6d-f0b801a1a781",
            "073a70ba-5bad-4560-b5ed-da512ddfe3ad",
            "1cf5b487-48d0-4e60-80ee-d05333542263",
            "4e82f2d5-b393-4940-9df7-3eb0a007daa0",
            "a06722ed-0113-4473-8932-4bca51c65305",
            "ab6970a5-dc33-4bfc-91c5-29f9b8aced75",
            "75f24a8d-96b2-4b51-b37f-efec1e96bfc2"
          ],
          "display_name": true,
          "domains": [
            "drug"
          ],
          "name_orgs": [
            {
              "uuid": "d8603480-c706-4b92-b584-eb0b7560aaef",
              "name_org": "INN"
            }
          ]
        },
        {
          "uuid": "b856a752-c082-64d9-9eac-5b25286e89d5",
          "name": "TETRACAINE [EP MONOGRAPH]",
          "stdName": "TETRACAINE [EP MONOGRAPH]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "e2233d0e-f0a8-b060-8a95-507d7e451935"
          ],
          "display_name": false
        },
        {
          "uuid": "24d8b70b-424a-4141-a528-e1740a600805",
          "name": "TETRACAINE [GREEN BOOK]",
          "stdName": "TETRACAINE [GREEN BOOK]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "a06722ed-0113-4473-8932-4bca51c65305"
          ],
          "display_name": false
        },
        {
          "uuid": "3a6e114d-9081-4b06-9de7-ae9d296f8d0d",
          "name": "TETRACAINE [MART.]",
          "stdName": "TETRACAINE [MART.]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "5107178e-00b8-4705-8b63-70365e6323b7"
          ],
          "display_name": false
        },
        {
          "uuid": "0ff39de7-1a0c-4c50-8da3-c41c623ec5f2",
          "name": "TETRACAINE [ORANGE BOOK]",
          "stdName": "TETRACAINE [ORANGE BOOK]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "1f60b997-985e-46bf-a5b1-b8aeaf8af9a0"
          ],
          "display_name": false
        },
        {
          "uuid": "2b8d722b-4a81-d519-3994-87e03cdf5afb",
          "name": "TETRACAINE [USP MONOGRAPH]",
          "stdName": "TETRACAINE [USP MONOGRAPH]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "735e7442-f8a1-90f6-f5e8-df5d33ee5e6e"
          ],
          "display_name": false
        },
        {
          "uuid": "d994ad13-0157-4b27-8c14-6a5eb32ea45c",
          "name": "TETRACAINE [USP-RS]",
          "stdName": "TETRACAINE [USP-RS]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "c05e0135-400d-4cea-beb7-9e7a082d9c38"
          ],
          "display_name": false
        },
        {
          "uuid": "59f4d4ff-9577-4fc8-a23a-efa5287d25a4",
          "name": "TETRACAINE [VANDF]",
          "stdName": "TETRACAINE [VANDF]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "1195c0f1-bd16-4f0d-83ad-6c0e6cd4aa3b"
          ],
          "display_name": false
        },
        {
          "uuid": "1dd1e41a-0990-0d22-66ac-b3dffc9cce09",
          "name": "Tetracaine [WHO-DD]",
          "stdName": "TETRACAINE [WHO-DD]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "5f3c78f7-d272-3f17-2063-1e17770fe918"
          ],
          "display_name": false
        },
        {
          "uuid": "1dab2b2c-eaa8-4f6e-8ea4-23f34317851e",
          "name": "tetracaine [INN]",
          "stdName": "TETRACAINE [INN]",
          "type": "cn",
          "languages": [
            "en"
          ],
          "preferred": false,
          "references": [
            "1cf5b487-48d0-4e60-80ee-d05333542263"
          ],
          "display_name": false
        }
      ],
      "references": [
        {
          "uuid": "13528cc5-a3c0-4040-8f6d-f0b801a1a781",
          "citation": "USP Dictionary 2008",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN",
            "PUBLIC_DOMAIN_RELEASE",
            "AUTO_SELECTED"
          ]
        },
        {
          "uuid": "d967f3e2-444e-4ef6-b975-6df3c48a7e43",
          "citation": "usp dictionary 2008",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "1cf5b487-48d0-4e60-80ee-d05333542263",
          "citation": "INN Proposed List 4",
          "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL04.pdf",
          "doc_type": "INN_LIST",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "4e82f2d5-b393-4940-9df7-3eb0a007daa0",
          "citation": "USP 33",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "8b7bc73d-2b1a-4889-8697-b94174b0bdae",
          "citation": "Drugs@FDA 2011",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "f2a20f26-2136-47cf-9f4b-3a00a64ec991",
          "citation": "Drugs@FDA 2012",
          "doc_type": "DRUGS@FDA",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "1f60b997-985e-46bf-a5b1-b8aeaf8af9a0",
          "citation": "ORANGE BOOK 2011",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "5107178e-00b8-4705-8b63-70365e6323b7",
          "citation": "MARTINDALE 2011",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "a06722ed-0113-4473-8932-4bca51c65305",
          "citation": "FDA SRS 2011",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "c05e0135-400d-4cea-beb7-9e7a082d9c38",
          "citation": "USP/NF",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "f2723895-2d93-46f9-b6fd-2567d4a2561a",
          "citation": "WHO-DD",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "1195c0f1-bd16-4f0d-83ad-6c0e6cd4aa3b",
          "citation": "NDF-RT",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "bc285564-2b3f-4839-ac9b-435671c412bd",
          "citation": "SRS CODE IMPORT",
          "doc_type": "SRS",
          "public_domain": true,
          "document_date": 1493389726000,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "779f6611-0719-416a-a659-21e7a3527f6a",
          "citation": "http://www.accessdata.fda.gov/spl/data/736e07fc-aa01-41c9-8d35-205deb7ea421/736e07fc-aa01-41c9-8d35-205deb7ea421.xml",
          "url": "http://www.accessdata.fda.gov/spl/data/736e07fc-aa01-41c9-8d35-205deb7ea421/736e07fc-aa01-41c9-8d35-205deb7ea421.xml",
          "doc_type": "WEBSITE",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "dc1d09ff-cf9b-48c1-8a32-e9cd8566a57e",
          "citation": "USP 36 TETRACAINE MONOGRAPH",
          "doc_type": "USP",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "0742f8d4-5469-4c0b-ae37-3712c38afb21",
          "citation": "SRS import [0619F35CGV]",
          "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=0619F35CGV",
          "doc_type": "SRS",
          "public_domain": true,
          "document_date": 1493389726000,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "4b9aa7e1-e92d-4153-a4dd-3ea8c799dec4",
          "citation": "CHEMID 2011",
          "doc_type": "SRS",
          "public_domain": true,
          "tags": [
            "NOMEN"
          ]
        },
        {
          "uuid": "75f24a8d-96b2-4b51-b37f-efec1e96bfc2",
          "citation": "TETRACAINE [INN]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "dcc93b8f-d1e9-463b-961f-e7a07b61eb18",
          "citation": "TETRACAINE [USP]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "ab6970a5-dc33-4bfc-91c5-29f9b8aced75",
          "citation": "TETRACAINE [ORANGE BOOK]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "073a70ba-5bad-4560-b5ed-da512ddfe3ad",
          "citation": "TETRACAINE [MART.]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "fad0ef1a-9e39-457c-8ec5-1239b45ecdbb",
          "citation": "TETRACAINE [GREEN BOOK]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "00436c54-39f7-4dbc-8a67-5c4ef34a91e5",
          "citation": "TETRACAINE [USP-RS]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "c9ad087f-6ffb-4460-81d4-2092220efffe",
          "citation": "TETRACAINE [WHO-DD]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "8004931f-572e-4a9d-86e9-32a78195eccf",
          "citation": "TETRACAINE [VANDF]",
          "doc_type": "SRS_LOCATOR",
          "public_domain": true
        },
        {
          "uuid": "22d6ff94-df1e-1b7b-5240-9d907e800834",
          "citation": "WEBSITE",
          "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=94-24-6",
          "doc_type": "WEBSITE",
          "public_domain": true,
          "tags": [
            "NOMEN",
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "1ab1e02a-6f0d-869b-14e1-28655127a121",
          "citation": "WEBSITE",
          "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+94-24-6",
          "doc_type": "WEBSITE",
          "public_domain": true,
          "tags": [
            "NOMEN",
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "1c60ae1e-c21d-037f-bf4c-f41734bedc54",
          "citation": "EU-SRS",
          "doc_type": "EMA LIST",
          "public_domain": true
        },
        {
          "uuid": "9167ec3a-a281-1614-423a-610c73e0f973",
          "doc_type": "SYSTEM",
          "public_domain": true
        },
        {
          "uuid": "a92ab2e4-4259-48a6-9a96-89b5596185a7",
          "citation": "STN",
          "doc_type": "STN (SCIFINDER)",
          "public_domain": true
        },
        {
          "uuid": "3c47a492-f7e4-461a-893d-2bd6c799c80f",
          "citation": "USP42-NF37 - 4257, Tetracaine Monograph",
          "doc_type": "USPNF",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "00d8fc89-5d5b-482c-92a3-2b14a29bcb0e",
          "citation": "USP42-NF37 - 4257, Tetracaine Monograph",
          "doc_type": "USPNF",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "a355b97d-f360-4181-bf07-b56011bbab22",
          "citation": "USP42-NF37 - 4257, Tetracaine Monograph",
          "doc_type": "USPNF",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "46850d0f-5033-6e67-6ffe-ddcf719da82a",
          "citation": "USP-RS",
          "doc_type": "USPNF",
          "public_domain": true
        },
        {
          "uuid": "e2233d0e-f0a8-b060-8a95-507d7e451935",
          "citation": "EP 10.5",
          "doc_type": "EP",
          "public_domain": true
        },
        {
          "uuid": "735e7442-f8a1-90f6-f5e8-df5d33ee5e6e",
          "citation": "USP/NF",
          "doc_type": "USPNF",
          "public_domain": true
        },
        {
          "uuid": "c48a0687-deae-9405-7752-66188d16a1cc",
          "citation": "DailyMed",
          "doc_type": "DAILYMED",
          "public_domain": true
        },
        {
          "uuid": "5f3c78f7-d272-3f17-2063-1e17770fe918",
          "citation": "WHO-DD",
          "doc_type": "WHO DRUG DICTIONARY",
          "public_domain": true
        },
        {
          "uuid": "af4d4ddd-83ba-4a1b-bc5a-4c70ec7d9102",
          "citation": "Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Table 1",
          "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related",
          "doc_type": "WEB PAGE",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "f220e5cd-dd4b-44b5-90b3-630441b9daaf",
          "citation": "Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Table 1",
          "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related",
          "doc_type": "WEB PAGE",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "26dadd46-3536-473f-85d2-62f8b0c16d96",
          "citation": "Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Table 1",
          "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related",
          "doc_type": "WEB PAGE",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        },
        {
          "uuid": "bab46137-12be-4c22-b6f0-13a0b8f982f4",
          "citation": "Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Table 1",
          "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related",
          "doc_type": "WEB PAGE",
          "public_domain": true,
          "tags": [
            "PUBLIC_DOMAIN_RELEASE"
          ]
        }
      ],
      "definition_type": "PRIMARY",
      "moieties": [
        {
          "uuid": "30d380df-5205-491e-9de8-cf75e2986af4",
          "id": "30d380df-5205-491e-9de8-cf75e2986af4",
          "molfile": "\n  Marvin  01132102372D          \n\n 19 19  0  0  0  0            999 V2000\n   -1.7536   -9.3861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.0397   -8.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3257   -9.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3883   -8.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.1023   -9.3986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    1.8205   -8.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.8205   -8.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.5344   -7.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.2484   -8.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.2484   -8.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.5344   -9.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.9624   -7.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.9624   -6.9143    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    4.6764   -8.1460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    5.3903   -7.7327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.1043   -8.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.8183   -7.7327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    6.8183   -6.9060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.5323   -8.1418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  1  0  0  0  0\n  6  7  1  0  0  0  0\n  6 11  2  0  0  0  0\n  7  8  2  0  0  0  0\n  8  9  1  0  0  0  0\n 10  9  2  0  0  0  0\n  9 12  1  0  0  0  0\n 11 10  1  0  0  0  0\n 13 12  2  0  0  0  0\n 14 12  1  0  0  0  0\n 15 14  1  0  0  0  0\n 16 15  1  0  0  0  0\n 17 16  1  0  0  0  0\n 18 17  1  0  0  0  0\n 19 17  1  0  0  0  0\nM  END",
          "smiles": "CCCCNc1ccc(cc1)C(=O)OCCN(C)C",
          "formula": "C15H24N2O2",
          "atropisomerism": "No",
          "charge": 0,
          "count": 1,
          "stereochemistry": "ACHIRAL",
          "count_amount": {
            "type": "MOL RATIO",
            "average": 1,
            "units": "MOL RATIO",
            "uuid": "c7298877-cbcc-4457-b353-6fb4859e7ee5"
          },
          "defined_stereo": 0,
          "ez_centers": 0,
          "molecular_weight": "264.3638",
          "optical_activity": "NONE",
          "stereo_centers": 0
        }
      ],
      "definition_level": "COMPLETE",
      "uuid": "b78fc0df-04de-4eaf-b1ea-c76e2f4c483c",
      "version": "37",
      "structure": {
        "id": "f7002b00-83fe-4afa-860f-139cdd788bda",
        "molfile": "\n  Marvin  01132112482D          \n\n 19 19  0  0  0  0            999 V2000\n    3.9624   -7.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.2484   -8.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.9624   -6.9143    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    3.2484   -8.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.5344   -7.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.6764   -8.1460    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    1.8205   -8.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.8183   -7.7327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    1.1023   -9.3986    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    1.8205   -8.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.5344   -9.3986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.3903   -7.7327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.1043   -8.1460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.3883   -8.9853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.8183   -6.9060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.5323   -8.1418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.3257   -9.3944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.0397   -8.9811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.7536   -9.3861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  1  0  0  0  0\n  3  1  2  0  0  0  0\n  4  2  1  0  0  0  0\n  5  2  2  0  0  0  0\n  6  1  1  0  0  0  0\n  7 10  2  0  0  0  0\n  8 13  1  0  0  0  0\n  9  7  1  0  0  0  0\n 10  5  1  0  0  0  0\n 11  4  2  0  0  0  0\n 12  6  1  0  0  0  0\n 13 12  1  0  0  0  0\n 14  9  1  0  0  0  0\n 15  8  1  0  0  0  0\n 16  8  1  0  0  0  0\n 17 14  1  0  0  0  0\n 18 17  1  0  0  0  0\n 19 18  1  0  0  0  0\n  7 11  1  0  0  0  0\nM  END",
        "smiles": "CCCCNc1ccc(cc1)C(=O)OCCN(C)C",
        "formula": "C15H24N2O2",
        "atropisomerism": "No",
        "charge": 0,
        "count": 1,
        "stereochemistry": "ACHIRAL",
        "defined_stereo": 0,
        "ez_centers": 0,
        "molecular_weight": "264.3638",
        "optical_activity": "NONE",
        "references": [
          "4b9aa7e1-e92d-4153-a4dd-3ea8c799dec4",
          "0742f8d4-5469-4c0b-ae37-3712c38afb21",
          "1cf5b487-48d0-4e60-80ee-d05333542263"
        ],
        "stereo_centers": 0
      },
      "unii": "0619F35CGV"
    }
  ]
}